The acute effect of different NAD+ precursors included in the combined metabolic activators.

[1]  D. Eidelberg,et al.  The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. , 2022, Cell metabolism.

[2]  N. Sabri,et al.  Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial , 2022, Therapeutic advances in chronic disease.

[3]  J. Nielsen,et al.  Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients , 2021, Molecular systems biology.

[4]  J. Błasiak,et al.  Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders , 2021, International journal of molecular sciences.

[5]  S. Harrison,et al.  Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease , 2021, The American journal of gastroenterology.

[6]  Danica Chen,et al.  The therapeutic promises of NAD+ boosters. , 2021, Cell metabolism.

[7]  A. Mouzaki,et al.  N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study , 2021, Infectious diseases.

[8]  J. Nielsen,et al.  Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19 , 2021, Advanced science.

[9]  J. Xia,et al.  MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..

[10]  A. Hevener,et al.  ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity , 2021, Science Translational Medicine.

[11]  E. Chini,et al.  Evolving concepts in NAD+ metabolism. , 2021, Cell metabolism.

[12]  S. Klein,et al.  Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women , 2021, Science.

[13]  N. Seidah,et al.  L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection , 2021, Nutrients.

[14]  S. Amini,et al.  Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial , 2020, European Journal of Pharmacology.

[15]  M. Mattson,et al.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing , 2020, Nature Reviews Drug Discovery.

[16]  A. Perl,et al.  Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine , 2020, Clinical Immunology.

[17]  G. Kroemer,et al.  Nutritional Aspects of Spermidine. , 2020, Annual review of nutrition.

[18]  Mark S. Schmidt,et al.  Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. , 2020, Cell metabolism.

[19]  J. Auwerx,et al.  Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans , 2020, The American journal of clinical nutrition.

[20]  J. Nielsen,et al.  The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease , 2020, Molecular systems biology.

[21]  D. Sinclair,et al.  Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers , 2020, Cells.

[22]  Ying Wang,et al.  COVID-19 infection: the perspectives on immune responses , 2020, Cell Death & Differentiation.

[23]  P. Wilmes,et al.  Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function. , 2020, Cell metabolism.

[24]  D. Sabatini,et al.  Dietary modifications for enhanced cancer therapy , 2020, Nature.

[25]  Michel E. Vandenberghe,et al.  Impairment of Glycolysis-Derived L-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease , 2019, SSRN Electronic Journal.

[26]  David A. Knowles,et al.  Molecular Choreography of Acute Exercise , 2020, Cell.

[27]  J. Auwerx,et al.  NAD+ homeostasis in health and disease , 2020, Nature Metabolism.

[28]  P. Chanson,et al.  Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case–control study , 2019, Psychiatry and clinical neurosciences.

[29]  E. Rhee,et al.  NAD+ homeostasis in renal health and disease , 2019, Nature Reviews Nephrology.

[30]  Mark S. Schmidt,et al.  Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures , 2019, Cell reports.

[31]  Markus M. Rinschen,et al.  Identification of bioactive metabolites using activity metabolomics , 2019, Nature Reviews Molecular Cell Biology.

[32]  D. Butterfield,et al.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease , 2019, Nature Reviews Neuroscience.

[33]  H. A. Abd El Latif,et al.  Improvement of insulin resistance via increase of GLUT4 and PPARγ in metabolic syndrome‐induced rats treated with omega‐3 fatty acid or l‐carnitine , 2018, Journal of biochemical and molecular toxicology.

[34]  Mark S. Schmidt,et al.  A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. , 2018, The American journal of clinical nutrition.

[35]  A. Whitworth,et al.  The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease. , 2018, Cell reports.

[36]  W. Le,et al.  Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[37]  M. McQueen,et al.  Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults , 2018, Nature Communications.

[38]  D. Sinclair,et al.  Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. , 2018, Cell metabolism.

[39]  M. Mattson,et al.  NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency , 2018, Proceedings of the National Academy of Sciences.

[40]  Guido Kroemer,et al.  Spermidine in health and disease , 2018, Science.

[41]  M. Mattson,et al.  Intermittent metabolic switching, neuroplasticity and brain health , 2018, Nature Reviews Neuroscience.

[42]  Hong Wang,et al.  Protein Expression Landscape of Mouse Embryos during Pre-implantation Development. , 2017, Cell reports.

[43]  B. Ogretmen,et al.  Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.

[44]  Jens Nielsen,et al.  Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD , 2017, Molecular systems biology.

[45]  P. Lewitt,et al.  Metabolomic biomarkers as strong correlates of Parkinson disease progression , 2017, Neurology.

[46]  K. Hirata,et al.  2-Aminobutyric acid modulates glutathione homeostasis in the myocardium , 2016, Scientific Reports.

[47]  Mark S. Schmidt,et al.  Nicotinamide riboside is uniquely and orally bioavailable in mice and humans , 2016, Nature Communications.

[48]  B. Gregory,et al.  Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle. , 2016, Cell metabolism.

[49]  G. Hatch,et al.  Mitochondrial phospholipids: role in mitochondrial function , 2016, Journal of Bioenergetics and Biomembranes.

[50]  B. Weinberger,et al.  Inherited disorders of bilirubin clearance , 2016, Pediatric Research.

[51]  I. Poon,et al.  The phospholipid code: a key component of dying cell recognition, tumor progression and host–microbe interactions , 2015, Cell Death and Differentiation.

[52]  Jens Nielsen,et al.  New paradigms for metabolic modeling of human cells. , 2015, Current opinion in biotechnology.

[53]  S. Claypool,et al.  Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes , 2015, Front. Genet..

[54]  J. Stuart,et al.  Unbalanced Activation of Glutathione Metabolic Pathways Suggests Potential Involvement in Plant Defense against the Gall Midge Mayetiola destructor in Wheat , 2015, Scientific Reports.

[55]  Malika Charrad,et al.  NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set , 2014 .

[56]  Sarah Spiegel,et al.  Sphingolipid metabolites in inflammatory disease , 2014, Nature.

[57]  M. Uhlén,et al.  Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[58]  Jens Nielsen,et al.  Genome‐scale modeling of human metabolism – a systems biology approach , 2013, Biotechnology journal.

[59]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[60]  David S. Wishart,et al.  MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..

[61]  Ulrich Klotz,et al.  Pharmacokinetics and drug metabolism in the elderly , 2009, Drug metabolism reviews.

[62]  R. Pamplona.  Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity. , 2008, Biochimica et biophysica acta.

[63]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[64]  Lokesh Kumar,et al.  Mfuzz: A software package for soft clustering of microarray data , 2007, Bioinformation.

[65]  H. Bays,et al.  Safety considerations with niacin therapy. , 2007, The American journal of cardiology.

[66]  Z. Benyó,et al.  GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. , 2005, The Journal of clinical investigation.

[67]  A. Tchernof,et al.  Lipid metabolism in the elderly , 2000, European journal of clinical nutrition.

[68]  Dean P. Jones,et al.  Redox state of glutathione in human plasma. , 2000, Free radical biology & medicine.

[69]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[70]  H. Jörnvall,et al.  Metabolism of glutathione and a glutathione conjugate by isolated kidney cells. , 1979, The Journal of biological chemistry.

[71]  T. Becker,et al.  Effects of lipids on mitochondrial functions. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[72]  Yuan Luo,et al.  A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[73]  S. Carrasco,et al.  Diacylglycerol, when simplicity becomes complex. , 2007, Trends in biochemical sciences.

[74]  J. Slotte,et al.  Cholesterol interactions with phospholipids in membranes. , 2002, Progress in lipid research.